10 January 2025 - takeover offer
The AIM-listed pharmaceutical company has revealed that is has agreed to be taken over by its largest shareholder DBAY Advisors with the latter offering 62.5p per share in cash. This is a useful premium to the closing share price yesterday of 44.35p. Regular readers will recall that we recommended the shares in the January 2024 issue of cityconfidential at a price of 38.9p, and so any readers who followed our tip will have made a gain of over 60% should they decide to accept the offer. As the offer has been . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
